Print

Pierre Fabre Medicament And Zambon Sign Commercial Agreement In Germany  
2/21/2007 5:14:34 PM

Philadelphia, Pennsylvania, February 19, 2007 – Plexus Ventures LLC, a global pharmaceutical business development firm, announced today the successful execution of an agreement between Pierre Fabre Medicament of France and Zambon S.p.A. of Italy. The deal, signed February 15, 2007, gives Pierre Fabre commercial rights for Zambon’s product portfolio in Germany.
//-->